XENON PHARMACEUTICALS INC (XENE)
CA98420N1050 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to XENE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 59.26. This target is 48.6% above the current price.
XENE was analyzed by 24 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about XENE.
In the previous month the buy percentage consensus was at a similar level.
XENE was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-01 | Needham | Maintains | Buy -> Buy |
| 2024-03-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-01 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-01-04 | Citigroup | Initiate | Buy |
| 2024-01-02 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-18 | Stifel | Maintains | Buy -> Buy |
| 2023-12-08 | Baird | Initiate | Outperform |
| 2023-11-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-22 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-08-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-07-17 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-15 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-05-10 | Wedbush | Maintains | Outperform |
| 2023-04-25 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-04-25 | JP Morgan | Maintains | Overweight |
| 2023-04-21 | Needham | Reiterate | Buy |
| 2023-03-22 | RBC Capital | Reiterate | Outperform |
| 2023-03-02 | Needham | Maintains | Buy |
| 2023-01-31 | RBC Capital | Maintains | Outperform |
| 2022-12-14 | Goldman Sachs | Initiate | Buy |
| 2022-12-12 | Cowen & Co. | Initiate | Outperform |
| 2022-11-28 | Wells Fargo | Initiate | Overweight |
| 2022-11-11 | Guggenheim | Maintains | Buy |
| 2022-10-19 | Raymond James | Initiate | Outperform |